Activity Description
  In this podcast Jacob Lang, OD and Cecelia Koetting, OD explore innovative treatments for Demodex blepharitis and MGD, highlighting real-world outcomes and emphasizing early intervention, personalized care, and patient adherence to improve eyelid margin health and maintain long-term therapeutic success.

Accreditation

Sponsored by






The Fundingsland Group, LLC is a COPE-Approved Administrator.

This activity, COPE Activity Number 129972, is accredited by COPE for continuing education for optometrists. This course is approved for .25 hours of CE.

Course # 95700-TD
Activity #: 129972

COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.

Release Date: 01-27-2025
Expiration Date: 01-27-2026

Grant Support Statement

This activity is supported by unrestricted educational grants from Johnson & Johnson Vision, Sight Sciences, and Tarsus Pharmaceuticals, Inc. 

Faculty